Skip to content
OpenCapital
Get started

Globus Medical GMED Available For Sale Debt Securities Noncurrent Accumulated Gross Unrealized Loss Before Tax

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept gmed:AvailableForSaleDebtSecuritiesNoncurrentAccumulatedGrossUnrealizedLossBeforeTax.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's available for sale debt securities noncurrent accumulated gross unrealized loss before tax.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's available for sale debt securities noncurrent accumulated gross unrealized loss before tax?
Globus Medical (GMED) reported available for sale debt securities noncurrent accumulated gross unrealized loss before tax of $792K in Q1 2026.
What is the long-term trend for Globus Medical's available for sale debt securities noncurrent accumulated gross unrealized loss before tax?
Over 4 years (2021 to 2025), Globus Medical's available for sale debt securities noncurrent accumulated gross unrealized loss before tax has grown at a -77.5% compound annual growth rate (CAGR), from $2.34M to $6K.